{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T23:33:30Z","timestamp":1781652810609,"version":"3.54.5"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,9,24]],"date-time":"2021-09-24T00:00:00Z","timestamp":1632441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,9,24]],"date-time":"2021-09-24T00:00:00Z","timestamp":1632441600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1007\/s12020-021-02877-w","type":"journal-article","created":{"date-parts":[[2021,9,24]],"date-time":"2021-09-24T21:51:09Z","timestamp":1632520269000},"page":"593-600","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["18F-Fluorocholine-PET combined with contrast-enhanced CT for localizing hyperfunctioning parathyroid glands and optimizing surgical treatment in patients with hyperparathyroidism"],"prefix":"10.1007","volume":"75","author":[{"given":"J\u00f6rn-Markus","family":"Gass","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinna","family":"Wicke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Mona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Strobel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Werner","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrg","family":"Metzger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Suter-Widmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Henzen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1659-343X","authenticated-orcid":false,"given":"Stefan","family":"Fischli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,24]]},"reference":[{"key":"2877_CR1","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1210\/jc.2012-4022","volume":"98","author":"MW Yeh","year":"2013","unstructured":"M.W. Yeh, P.H.G. Ituarte, H.C. Zhou, S. Nishimoto, I.-L.A. Liu, A. Harari, P.I. Haigh, A.L. Adams, Incidence and prevalence of primary hyperparathyroidism in a racially mixed population. J. Clin. Endocrinol. Metab. 98, 1122\u20131129 (2013). https:\/\/doi.org\/10.1210\/jc.2012-4022","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2877_CR2","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1359\/JBMR.050910","volume":"21","author":"RA Wermers","year":"2006","unstructured":"R.A. Wermers, S. Khosla, E.J. Atkinson, S.J. Achenbach, A.L. Oberg, C.S. Grant, L.J. Melton, Incidence of primary hyperparathyroidism in Rochester, Minnesota, 1993-2001: an update on the changing epidemiology of the disease. J. Bone Min. Res J. Am. Soc. Bone Min. Res 21, 171\u2013177 (2006). https:\/\/doi.org\/10.1359\/JBMR.050910","journal-title":"J. Bone Min. Res J. Am. Soc. Bone Min. Res"},{"key":"2877_CR3","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1016\/j.surg.2013.06.051","volume":"154","author":"DM Press","year":"2013","unstructured":"D.M. Press, A.E. Siperstein, E. Berber, J.J. Shin, R. Metzger, R. Monteiro, J. Mino, W. Swagel, J.C. Mitchell, The prevalence of undiagnosed and unrecognized primary hyperparathyroidism: a population-based analysis from the electronic medical record. Surgery 154, 1232\u20131237 (2013). https:\/\/doi.org\/10.1016\/j.surg.2013.06.051. discussion 1237\u20131238","journal-title":"Surgery"},{"key":"2877_CR4","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/nrendo.2017.104","volume":"14","author":"MD Walker","year":"2018","unstructured":"M.D. Walker, S.J. Silverberg, Primary hyperparathyroidism. Nat. Rev. Endocrinol. 14, 115\u2013125 (2018). https:\/\/doi.org\/10.1038\/nrendo.2017.104","journal-title":"Nat. Rev. Endocrinol."},{"key":"2877_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00198-016-3716-2","volume":"28","author":"AA Khan","year":"2017","unstructured":"A.A. Khan, D.A. Hanley, R. Rizzoli, J. Bollerslev, J.E.M. Young, L. Rejnmark, R. Thakker, P. D\u2019Amour, T. Paul, S. Van Uum et al. Primary hyperparathyroidism: review and recommendations on evaluation, diagnosis, and management. A Canadian and international consensus. Osteoporos. Int J. Establ Result Coop. Eur. Found. Osteoporos. Natl Osteoporos. Found. USA 28, 1\u201319 (2017). https:\/\/doi.org\/10.1007\/s00198-016-3716-2","journal-title":"Osteoporos. Int J. Establ Result Coop. Eur. Found. Osteoporos. Natl Osteoporos. Found. USA"},{"key":"2877_CR6","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/S0140-6736(17)31430-7","volume":"391","author":"JP Bilezikian","year":"2018","unstructured":"J.P. Bilezikian, L. Bandeira, A. Khan, N.E. Cusano, Hyperparathyroidism. Lancet Lond. Engl. 391, 168\u2013178 (2018). https:\/\/doi.org\/10.1016\/S0140-6736(17)31430-7","journal-title":"Lancet Lond. Engl."},{"key":"2877_CR7","first-page":"861","volume":"131","author":"W Shen","year":"1996","unstructured":"W. Shen, M. D\u00fcren, E. Morita, C. Higgins, Q.Y. Duh, A.E. Siperstein, O.H. Clark, Reoperation for persistent or recurrent primary hyperparathyroidism. Arch. Surg. Chic. Ill. 1960 131, 861\u2013867 (1996). discussion 867-869","journal-title":"Arch. Surg. Chic. Ill. 1960"},{"key":"2877_CR8","first-page":"14","volume":"95","author":"G Akerstr\u00f6m","year":"1984","unstructured":"G. Akerstr\u00f6m, J. Malmaeus, R. Bergstr\u00f6m, Surgical anatomy of human parathyroid glands. Surgery 95, 14\u201321 (1984)","journal-title":"Surgery"},{"key":"2877_CR9","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1097\/SLA.0b013e318208fed9","volume":"253","author":"R Udelsman","year":"2011","unstructured":"R. Udelsman, Z. Lin, P. Donovan, The superiority of minimally invasive parathyroidectomy based on 1650 consecutive patients with primary hyperparathyroidism. Ann. Surg. 253, 585\u2013591 (2011). https:\/\/doi.org\/10.1097\/SLA.0b013e318208fed9","journal-title":"Ann. Surg."},{"key":"2877_CR10","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1001\/jamasurg.2016.2310","volume":"151","author":"SM Wilhelm","year":"2016","unstructured":"S.M. Wilhelm, T.S. Wang, D.T. Ruan, J.A. Lee, S.L. Asa, Q.-Y. Duh, G.M. Doherty, M.F. Herrera, J.L. Pasieka, N.D. Perrier et al. The American association of endocrine surgeons guidelines for definitive management of primary hyperparathyroidism. JAMA Surg. 151, 959 (2016). https:\/\/doi.org\/10.1001\/jamasurg.2016.2310","journal-title":"JAMA Surg."},{"key":"2877_CR11","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/s00423-021-02173-1","volume":"406","author":"T Weber","year":"2021","unstructured":"T. Weber, C. Dotzenrath, H. Dralle, B. Niederle, P. Riss, K. Holzer, J. Ku\u00dfmann, A. Trupka, T. Negele, R. Kaderli et al. Management of primary and renal hyperparathyroidism: guidelines from the German Association of Endocrine Surgeons (CAEK). Langenbecks Arch. Surg. 406, 571\u2013585 (2021). https:\/\/doi.org\/10.1007\/s00423-021-02173-1","journal-title":"Langenbecks Arch. Surg."},{"key":"2877_CR12","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.otohns.2004.10.005","volume":"132","author":"JM Ruda","year":"2005","unstructured":"J.M. Ruda, C.S. Hollenbeak, B.C. Stack, A systematic review of the diagnosis and treatment of primary hyperparathyroidism from 1995 to 2003. Otolaryngol.\u2013Head. Neck Surg. J. Am. Acad. Otolaryngol.-Head. Neck Surg. 132, 359\u2013372 (2005). https:\/\/doi.org\/10.1016\/j.otohns.2004.10.005","journal-title":"Otolaryngol.\u2013Head. Neck Surg. J. Am. Acad. Otolaryngol.-Head. Neck Surg."},{"key":"2877_CR13","doi-asserted-by":"publisher","first-page":"17","DOI":"10.15557\/JoU.2017.0002","volume":"17","author":"M Kobylecka","year":"2017","unstructured":"M. Kobylecka, M.T. P\u0142azi\u0144ska, W. Chudzi\u0144ski, K. Fronczewska-Wieniawska, J. M\u0105czewska, A. Bajera, M. Karli\u0144ska, L. Kr\u00f3licki, Comparison of scintigraphy and ultrasound imaging in patients with primary, secondary and tertiary hyperparathyroidism - own experience. J. Ultrason 17, 17\u201322 (2017). https:\/\/doi.org\/10.15557\/JoU.2017.0002","journal-title":"J. Ultrason"},{"key":"2877_CR14","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1007\/s00259-018-3980-9","volume":"45","author":"M Beheshti","year":"2018","unstructured":"M. Beheshti, L. Hehenwarter, Z. Paymani, G. Rendl, L. Imamovic, R. Rettenbacher, O. Tsybrovskyy, W. Langsteger, C. Pirich, 18F-Fluorocholine PET\/CT in the assessment of primary hyperparathyroidism compared with 99mTc-MIBI or 99mTc-tetrofosmin SPECT\/CT: a prospective dual-centre study in 100 patients. Eur. J. Nucl. Med Mol. Imaging 45, 1762\u20131771 (2018). https:\/\/doi.org\/10.1007\/s00259-018-3980-9","journal-title":"Eur. J. Nucl. Med Mol. Imaging"},{"key":"2877_CR15","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1148\/radiol.2019182122","volume":"291","author":"R Yeh","year":"2019","unstructured":"R. Yeh, Y.-K.D. Tay, G. Tabacco, L. Dercle, J.H. Kuo, L. Bandeira, C. McManus, D.K. Leung, J.A. Lee, J.P. Bilezikian, Diagnostic performance of 4D CT and Sestamibi SPECT\/CT in localizing parathyroid adenomas in primary hyperparathyroidism. Radiology 291, 469\u2013476 (2019). https:\/\/doi.org\/10.1148\/radiol.2019182122","journal-title":"Radiology"},{"key":"2877_CR16","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.2967\/jnumed.108.054858","volume":"49","author":"DR Neumann","year":"2008","unstructured":"D.R. Neumann, N.A. Obuchowski, F.P. Difilippo, Preoperative 123I\/99mTc-sestamibi subtraction SPECT and SPECT\/CT in primary hyperparathyroidism. J. Nucl. Med Publ. Soc. Nucl. Med 49, 2012\u20132017 (2008). https:\/\/doi.org\/10.2967\/jnumed.108.054858","journal-title":"J. Nucl. Med Publ. Soc. Nucl. Med"},{"key":"2877_CR17","doi-asserted-by":"publisher","first-page":"e491","DOI":"10.1097\/RLU.0000000000001845","volume":"42","author":"N Thanseer","year":"2017","unstructured":"N. Thanseer, S.K. Bhadada, A. Sood, B.R. Mittal, A. Behera, A.K.R. Gorla, R.R. Kalathoorakathu, P. Singh, D. Dahiya, U.N. Saikia et al. Comparative effectiveness of ultrasonography, 99mTc-Sestamibi, and 18F-Fluorocholine PET\/CT in detecting parathyroid adenomas in patients with primary hyperparathyroidism. Clin. Nucl. Med 42, e491\u2013e497 (2017). https:\/\/doi.org\/10.1097\/RLU.0000000000001845","journal-title":"Clin. Nucl. Med"},{"key":"2877_CR18","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1007\/s12672-018-0347-4","volume":"9","author":"S-J Kim","year":"2018","unstructured":"S.-J. Kim, S.-W. Lee, S.Y. Jeong, K. Pak, K. Kim, Diagnostic performance of F-18 fluorocholine PET\/CT for parathyroid localization in hyperparathyroidism: a systematic review and meta-analysis. Horm. Cancer 9, 440\u2013447 (2018). https:\/\/doi.org\/10.1007\/s12672-018-0347-4","journal-title":"Horm. Cancer"},{"key":"2877_CR19","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1007\/s00259-018-4123-z","volume":"46","author":"G Treglia","year":"2019","unstructured":"G. Treglia, A. Piccardo, A. Imperiale, K. Strobel, P.A. Kaufmann, J.O. Prior, L. Giovanella, Diagnostic performance of choline PET for detection of hyperfunctioning parathyroid glands in hyperparathyroidism: a systematic review and meta-analysis. Eur. J. Nucl. Med Mol. Imaging 46, 751\u2013765 (2019). https:\/\/doi.org\/10.1007\/s00259-018-4123-z","journal-title":"Eur. J. Nucl. Med Mol. Imaging"},{"key":"2877_CR20","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.ejso.2016.09.016","volume":"43","author":"M Hocevar","year":"2017","unstructured":"M. Hocevar, L. Lezaic, S. Rep, K. Zaletel, T. Kocjan, M.J. Sever, J. Zgajnar, B. Peric, Focused parathyroidectomy without intraoperative parathormone testing is safe after pre-operative localization with 18F-Fluorocholine PET\/CT. Eur. J. Surg. Oncol. J. Eur. Soc. Surg. Oncol. Br. Assoc. Surg. Oncol. 43, 133\u2013137 (2017). https:\/\/doi.org\/10.1016\/j.ejso.2016.09.016","journal-title":"Eur. J. Surg. Oncol. J. Eur. Soc. Surg. Oncol. Br. Assoc. Surg. Oncol."},{"key":"2877_CR21","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1007\/s00259-017-3911-1","volume":"45","author":"E Quak","year":"2018","unstructured":"E. Quak, D. Blanchard, B. Houdu, Y. Le Roux, R. Ciappuccini, B. Lireux, D. de Raucourt, J.-M. Grellard, I. Licaj, S. Bardet et al. F18-choline PET\/CT guided surgery in primary hyperparathyroidism when ultrasound and MIBI SPECT\/CT are negative or inconclusive: the APACH1 study. Eur. J. Nucl. Med Mol. Imaging 45, 658\u2013666 (2018). https:\/\/doi.org\/10.1007\/s00259-017-3911-1","journal-title":"Eur. J. Nucl. Med Mol. Imaging"},{"key":"2877_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s13550-019-0544-3","volume":"9","author":"WAM Broos","year":"2019","unstructured":"W.A.M. Broos, M. Wondergem, R.J.J. Knol, F.M. van der Zant, Parathyroid imaging with 18F-fluorocholine PET\/CT as a first-line imaging modality in primary hyperparathyroidism: a retrospective cohort study. EJNMMI Res 9, 72 (2019). https:\/\/doi.org\/10.1186\/s13550-019-0544-3","journal-title":"EJNMMI Res"},{"key":"2877_CR23","doi-asserted-by":"publisher","first-page":"664","DOI":"10.3390\/diagnostics11040664","volume":"11","author":"L Sun","year":"2021","unstructured":"L. Sun, J. Yao, P. Hao, Y. Yang, Z. Liu, R. Peng, Diagnostic role of four-dimensional computed tomography for preoperative parathyroid localization in patients with primary hyperparathyroidism: a systematic review and meta-analysis. Diagn. Basel Switz. 11, 664 (2021). https:\/\/doi.org\/10.3390\/diagnostics11040664","journal-title":"Diagn. Basel Switz."},{"key":"2877_CR24","doi-asserted-by":"publisher","first-page":"380","DOI":"10.3389\/fendo.2017.00380","volume":"8","author":"S Fischli","year":"2017","unstructured":"S. Fischli, I. Suter-Widmer, B.T. Nguyen, W. M\u00fcller, J. Metzger, K. Strobel, H. Gr\u00fcnig, C. Henzen, The significance of 18F-Fluorocholine-PET\/CT as localizing imaging technique in patients with primary hyperparathyroidism and negative conventional imaging. Front Endocrinol. 8, 380 (2017). https:\/\/doi.org\/10.3389\/fendo.2017.00380","journal-title":"Front Endocrinol."},{"key":"2877_CR25","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1097\/00000658-200201000-00013","volume":"235","author":"F-F Chou","year":"2002","unstructured":"F.-F. Chou, C.-H. Lee, H.-Y. Chen, J.-B. Chen, K.-T. Hsu, S.-M. Sheen-Chen, Persistent and recurrent hyperparathyroidism after total parathyroidectomy with autotransplantation. Ann. Surg. 235, 99\u2013104 (2002)","journal-title":"Ann. Surg."},{"key":"2877_CR26","unstructured":"EUROCRINE registry. Available at: https:\/\/eurocrine.eu\/ [Accessed April 13, 2021]"},{"key":"2877_CR27","doi-asserted-by":"publisher","first-page":"2272","DOI":"10.1245\/s10434-012-2325-3","volume":"19","author":"BM Dy","year":"2012","unstructured":"B.M. Dy, M.L. Richards, B.J. Vazquez, G.B. Thompson, D.R. Farley, C.S. Grant, Primary hyperparathyroidism and negative Tc99 sestamibi imaging: to operate or not? Ann. Surg. Oncol. 19, 2272\u20132278 (2012). https:\/\/doi.org\/10.1245\/s10434-012-2325-3","journal-title":"Ann. Surg. Oncol."},{"key":"2877_CR28","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s00423-012-1004-y","volume":"398","author":"E Karakas","year":"2013","unstructured":"E. Karakas, H.-H. M\u00fcller, T. Schlosshauer, M. Rothmund, D.K. Bartsch, Reoperations for primary hyperparathyroidism\u2013improvement of outcome over two decades. Langenbecks Arch. Surg. 398, 99\u2013106 (2013). https:\/\/doi.org\/10.1007\/s00423-012-1004-y","journal-title":"Langenbecks Arch. Surg."},{"key":"2877_CR29","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1007\/s00268-016-3795-4","volume":"41","author":"T Weber","year":"2017","unstructured":"T. Weber, M. Gottstein, S. Schwenzer, A. Beer, M. Luster, Is C-11 Methionine PET\/CT Able to Localise Sestamibi-Negative Parathyroid Adenomas? World J. Surg. 41, 980\u2013985 (2017). https:\/\/doi.org\/10.1007\/s00268-016-3795-4","journal-title":"World J. Surg."},{"key":"2877_CR30","doi-asserted-by":"publisher","unstructured":"P. Petranovi\u0107 Ov\u010dari\u010dek, L. Giovanella, I. Carri\u00f3 Gasset, E. Hindi\u201a M.W. Huellner, M. Luster, A. Piccardo, T. Weber, J.-N. Talbot, F.A. Verburg, The EANM practice guidelines for parathyroid imaging. Eur J Nucl Med Mol Imaging (2021). https:\/\/doi.org\/10.1007\/s00259-021-05334-y","DOI":"10.1007\/s00259-021-05334-y"},{"key":"2877_CR31","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1530\/EJE-21-0038","volume":"185","author":"F Bioletto","year":"2021","unstructured":"F. Bioletto, M. Barale, M. Parasiliti-Caprino, N. Prencipe, A.M. Berton, M. Procopio, D. Deandreis, E. Ghigo, Comparison of the diagnostic accuracy of 18F-Fluorocholine PET and 11C-Methionine PET for parathyroid localization in primary hyperparathyroidism: a systematic review and meta-analysis. Eur. J. Endocrinol. 185, 109\u2013120 (2021). https:\/\/doi.org\/10.1530\/EJE-21-0038","journal-title":"Eur. J. Endocrinol."},{"key":"2877_CR32","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1088\/1361-6498\/aaa86f","volume":"38","author":"S Rep","year":"2018","unstructured":"S. Rep, M. Hocevar, J. Vaupotic, U. Zdesar, K. Zaletel, L. Lezaic, 18F-choline PET\/CT for parathyroid scintigraphy: significantly lower radiation exposure of patients in comparison to conventional nuclear medicine imaging approaches. J. Radio. Prot. J. Soc. Radio. Prot. 38, 343\u2013356 (2018). https:\/\/doi.org\/10.1088\/1361-6498\/aaa86f","journal-title":"J. Radio. Prot. J. Soc. Radio. Prot."},{"key":"2877_CR33","doi-asserted-by":"publisher","first-page":"e1701","DOI":"10.1097\/MD.0000000000001701","volume":"94","author":"L Michaud","year":"2015","unstructured":"L. Michaud, S. Balogova, A. Burgess, J. Ohnona, V. Huchet, K. Kerrou, M. Lef\u00e8vre, M. Tassart, F. Montravers, S. P\u00e9ri\u00e9 et al. A pilot comparison of 18F-fluorocholine PET\/CT, ultrasonography and 123I\/99mTc-sestaMIBI dual-phase dual-isotope scintigraphy in the preoperative localization of hyperfunctioning parathyroid glands in primary or secondary hyperparathyroidism: influence of thyroid anomalies. Med. (Baltim.) 94, e1701 (2015). https:\/\/doi.org\/10.1097\/MD.0000000000001701","journal-title":"Med. (Baltim.)"},{"key":"2877_CR34","doi-asserted-by":"publisher","first-page":"577","DOI":"10.2967\/jnumed.119.229914","volume":"61","author":"A Cuderman","year":"2020","unstructured":"A. Cuderman, K. Senica, S. Rep, M. Hocevar, T. Kocjan, M.J. Sever, K. Zaletel, L. Lezaic, 18F-Fluorocholine PET\/CT in primary hyperparathyroidism: superior diagnostic performance to conventional scintigraphic imaging for localization of hyperfunctioning parathyroid glands. J. Nucl. Med Publ. Soc. Nucl. Med 61, 577\u2013583 (2020). https:\/\/doi.org\/10.2967\/jnumed.119.229914","journal-title":"J. Nucl. Med Publ. Soc. Nucl. Med"},{"key":"2877_CR35","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1007\/s00259-020-04680-7","volume":"47","author":"DA L\u00f3pez-Mora","year":"2020","unstructured":"D.A. L\u00f3pez-Mora, M. Sizova, M. Estorch, A. Flotats, V. Camacho, A. Fern\u00e1ndez, S. Abouzian, F. Fuentes-Ocampo, J.I.P. Garcia, A.I.C. Ballesteros et al. Superior performance of 18F-fluorocholine digital PET\/CT in the detection of parathyroid adenomas. Eur. J. Nucl. Med Mol. Imaging 47, 572\u2013578 (2020). https:\/\/doi.org\/10.1007\/s00259-020-04680-7","journal-title":"Eur. J. Nucl. Med Mol. Imaging"},{"key":"2877_CR36","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.surg.2016.05.049","volume":"161","author":"I Lou","year":"2017","unstructured":"I. Lou, C. Balentine, S. Clarkson, D.F. Schneider, R.S. Sippel, H. Chen, How long should we follow patients after apparently curative parathyroidectomy? Surgery 161, 54\u201361 (2017). https:\/\/doi.org\/10.1016\/j.surg.2016.05.049","journal-title":"Surgery"},{"key":"2877_CR37","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.surg.2019.05.076","volume":"167","author":"R Mallick","year":"2020","unstructured":"R. Mallick, K.J. Nicholson, L. Yip, S.E. Carty, K.L. McCoy, Factors associated with late recurrence after parathyroidectomy for primary hyperparathyroidism. Surgery 167, 160\u2013165 (2020). https:\/\/doi.org\/10.1016\/j.surg.2019.05.076","journal-title":"Surgery"},{"key":"2877_CR38","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s12020-020-02487-y","volume":"71","author":"L Giovanella","year":"2021","unstructured":"L. Giovanella, L. Bacigalupo, G. Treglia, A. Piccardo, Will 18F-fluorocholine PET\/CT replace other methods of preoperative parathyroid imaging? Endocrine 71, 285\u2013297 (2021). https:\/\/doi.org\/10.1007\/s12020-020-02487-y","journal-title":"Endocrine"}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-021-02877-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-021-02877-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-021-02877-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,4]],"date-time":"2022-02-04T13:41:45Z","timestamp":1643982105000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-021-02877-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,24]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["2877"],"URL":"https:\/\/doi.org\/10.1007\/s12020-021-02877-w","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,24]]},"assertion":[{"value":"11 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Written informed consent was obtained from all patients, and the study was approved by the local ethics committee. (Ethikkomission Nordwest- und Zentralschweiz, EKNZ, Nr. 2020\u201302142)","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}